Ropes & Gray represented Davidson Kempner Capital Management and Highbridge Capital Management in a convertible note exchange and purchase transaction with biotech company, Biora Therapeutics Inc., reducing Biora’s debt by 60%, coupled with a maturity extension and the provision of $16.7 million in new capital to Biora. The transaction was announced in a December 18 press release.
Davidson Kempner Capital Management is a global investment management firm with over 40 years of experience and a focus on fundamental investing with a multi-strategy approach.
Highbridge Capital Management is a global alternative investment firm offering credit and volatility focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles, and co-investments.
This team was led by finance partners Sam Badawi and Alyson Gal and IP transactions partner Melissa Rones.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.